Search

Author/Creator Muñoz, F

1. DOP32 Long-term outcomes of enterocutaneous fistula complicating Crohn's Disease: The ECUFIT study from GETECCU. (27th May 2021)

Authors:
Rodríguez-Lago, I; García Pérez, C; Calafat, M; Soto, M P; Calvo, M; Sánchez Rodríguez, E; Caballol, B; Vela, M; Rivero, M; Muñoz, F; De Castro, L; Calvet, X; García-Alonso, F J; Utrilla Fornals, A; Ferreiro-Iglesias, R; González-Muñoza, C; Chaparro, M; Luis, B; Sicilia, B; Alfambra, E
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S070
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Evolution After Anti‐TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long‐Term Follow‐Up Study. (January 2017)

Authors:
Casanova, M J; Chaparro, M; García‐Sánchez, V; Nantes, O; Leo, E; Rojas‐Feria, M; Jauregui‐Amezaga, A; García‐López, S; Huguet, J M; Arguelles‐Arias, F; Aicart, M; Marín‐Jiménez, I; Gómez‐García, M; Muñoz, F; Esteve, M; Bujanda, L; Cortés, X; Tosca, J; Pineda, J R; Mañosa, M
Journal:
American journal of gastroenterology
Issue:
Volume 112:Number 1(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Inflammatory Bowel Disease (IBD) and immunosuppression do not worsen the prognosis of COVID-19. Results from the ENEIDA Project of GETECCU. (27th May 2021)

Authors:
Zabana Abdo, Y; Marín-Jiménez, I; Rodríguez-Lago, I; Ramírez Esteso, F; Meijilde, S; Ramos, L; Gomollón, F; Muñoz, F; Suris, G; Ortiz de Zárate, J; Huguet, J M; Llaó, J; García-Sepulcre, M; Sierra, M; Durà, M; Estrecha, S; Fuentes Coronel, A; Hinojosa, E; Olivan, L; Iglesias, E
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S553
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Long‐Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid‐Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989–2013): A Nationwide Multicenter Study. (November 2017)

Authors:
Ordás, I; Domènech, E; Mañosa, M; García‐Sánchez, V; Iglesias‐Flores, E; Peñalva, M; Cañas‐Ventura, A; Merino, O; Fernández‐Bañares, F; Gomollón, F; Vera, M; Gutiérrez, A; Garcia‐Planella, E; Chaparro, M; Aguas, M; Gento, E; Muñoz, F; Aguirresarobe, M; Muñoz, C; Fernández, L
Journal:
American journal of gastroenterology
Issue:
Volume 112:Number 11(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. P122 Low Risk of new dysplastic lesions during inflammatory bowel disease surveillance with dye-cromoendoscopy: a multicenter population-based retrospective study. (21st January 2022)

Authors:
Saiz Chumillas, R M; Alba, L; Gonzalez-Lama, Y; Velayos, B; Suarez, P; Maroto-Martin, C; Nuñez, A; Hernandez, L; Relea, L; Fernandez-Salazar, L; Sierra-Ausin, M; Barrio, J; Muñoz, F; Arias, L; Sicilia, B
Journal:
Journal of Crohn's and colitis
Issue:
Volume 16(2022)Supplement 1
Page Start:
i211
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. P433 Intravenous ustekinumab as maintenance treatment is effective in patients with partial or loss of response to optimized ustekinumab sc. (21st January 2022)

Authors:
Garcia-Alvarado, M; Barrio, J; Sierra-Ausin, M; Arias, L; Fernández-Salazar, L; Fuentes Coronel, A; Arias García, L; García-Alonso, F J; García-Prada, M; Legido, J; Sánchez-Hernández, J G; Muñoz, F
Journal:
Journal of Crohn's and colitis
Issue:
Volume 16(2022)Supplement 1
Page Start:
i416
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. P443 Clinical features, therapeutic requirements, and evolution of patients with Crohn's disease and upper digestive tract involvement (CROHNEX study). (25th January 2019)

Authors:
Sainz Arnau, E; Zabana, Y; Miguel, I; Fernández Clotet, A; Casanova, M J; Martín, M D; Picó, M D; Alfambra, E; Rodriguez, I; Muñoz, F; Domínguez, M; Iglesias, E; Busquets, D; Gutiérrez, A; Cañete, F; Nuñez, L; Taxonera, C; Beltrán, B; Camps, B; Calvet, X
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S332
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. P634 Ustekinumab and vedolizumab as first-line biological therapy for inflammatory bowel disease. A multicenter study based on the ENEIDA registry. (30th January 2023)

Authors:
Calafat Sard, M; Pascual, I; Nos, P; Barrio, J; Gutiérrez, A; Martín-Arranz, M D; Ricart, E; Gomollón, F; Sierra Ausín, M; Huguet, J M; Guardiola, J; Vera, I; Varela, P; Iglesias, E; Garcia-Planella, E; de Castro, L; García Sepulcre, M F; Sicilia, B; Fernández-Salazar, L; Calvet, X
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i766
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗